Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer
This trial is active, not recruiting.
|Sponsor||National University Hospital, Singapore|
|Start date||September 2011|
|End date||December 2014|
|Trial identifier||NCT01100814, GA01/08/08|
The investigators hypothesize that aberrant hypermethylation of tumour suppressor genes is an important mechanism for Epstein-Barr Virus (EBV) - related gastric carcinogenesis, the promoter hypermethylation status and the expression of S100A2 and TFF1 might be different between EBV-associated gastric cancer (GC) and non EBV-associated GC.
|Observational model||case control|
Male or female participants of any age.
Inclusion Criteria: - Nil Exclusion Criteria: - Nil
|Official title||Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer|
Call for more information